MDT Medtronic plc
Price (delayed)
$88.49
Market cap
$113.49B
P/E Ratio
26.73
Dividend/share
$2.8
EPS
$3.31
Enterprise value
$138.86B
Medtronic plc, headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around
Highlights
The price to earnings (P/E) is 16% lower than the 5-year quarterly average of 31.7 and 2.8% lower than the last 4 quarters average of 27.5
The EPS rose by 5% year-on-year
MDT's debt is down by 6% since the previous quarter but it is up by 6% year-on-year
Medtronic's quick ratio has decreased by 18% YoY
The company's equity fell by 4.6% YoY
Key stats
What are the main financial stats of MDT
Market
Valuations
Earnings
Shares outstanding
1.28B
Market cap
$113.49B
Enterprise value
$138.86B
Price to earnings (P/E)
26.73
Price to book (P/B)
2.3
Price to sales (P/S)
3.42
EV/EBIT
23.33
EV/EBITDA
16.1
EV/Sales
4.18
Revenue
$33.2B
Gross profit
$21.67B
Operating income
$5.57B
Net income
$4.26B
EBIT
$5.95B
EBITDA
$8.63B
Free cash flow
$5.47B
Per share
Balance sheet
Liquidity
EPS
$3.31
EPS diluted
$3.29
Free cash flow per share
$4.26
Book value per share
$38.51
Revenue per share
$25.89
TBVPS
$28.83
Total assets
$89.97B
Total liabilities
$40.36B
Debt
$26.61B
Equity
$49.39B
Working capital
$10.67B
Debt to equity
0.54
Current ratio
1.9
Quick ratio
1.19
Net debt/EBITDA
2.94
Margins
Efficiency
Dividend
EBITDA margin
26%
Gross margin
65.3%
Net margin
12.8%
Operating margin
16.8%
Return on assets
4.7%
Return on equity
8.7%
Return on invested capital
11.8%
Return on capital employed
7.6%
Return on sales
17.9%
Dividend yield
3.16%
DPS
$2.8
Payout ratio
84.6%
MDT stock price
How has the Medtronic stock price performed over time
Intraday
-1.52%
1 week
-0.11%
1 month
-3.84%
1 year
1.69%
YTD
10.78%
QTD
-1.52%
Financial performance
How have Medtronic's revenue and profit performed over time
Revenue
$33.2B
Gross profit
$21.67B
Operating income
$5.57B
Net income
$4.26B
Gross margin
65.3%
Net margin
12.8%
The operating margin has declined by 4% year-on-year but it has increased by 2.4% since the previous quarter
Medtronic's revenue has increased by 2.7% YoY
The operating income has increased by 3% QoQ
MDT's gross profit is up by 2.4% year-on-year
Growth
What is Medtronic's growth rate over time
Valuation
What is Medtronic stock price valuation
P/E
26.73
P/B
2.3
P/S
3.42
EV/EBIT
23.33
EV/EBITDA
16.1
EV/Sales
4.18
The price to earnings (P/E) is 16% lower than the 5-year quarterly average of 31.7 and 2.8% lower than the last 4 quarters average of 27.5
The EPS rose by 5% year-on-year
The stock's price to book (P/B) is 8% less than its 5-year quarterly average of 2.5 but 4.5% more than its last 4 quarters average of 2.2
The company's equity fell by 4.6% YoY
MDT's P/S is 19% lower than its 5-year quarterly average of 4.2 but 3.6% higher than its last 4 quarters average of 3.3
Medtronic's revenue has increased by 2.7% YoY
Efficiency
How efficient is Medtronic business performance
The return on sales has declined by 7% year-on-year
Medtronic's return on equity has increased by 6% YoY
The company's return on invested capital fell by 6% YoY
MDT's return on assets is up by 2.2% year-on-year but it is down by 2.1% since the previous quarter
Dividends
What is MDT's dividend history
DPS
$2.8
Dividend yield
3.16%
Payout ratio
84.6%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Medtronic financials performed over time
The total assets is 123% greater than the total liabilities
Medtronic's quick ratio has decreased by 18% YoY
The company's current ratio fell by 17% YoY but it rose by 3.3% QoQ
MDT's debt is 46% smaller than its equity
Medtronic's debt to equity has increased by 10% YoY but it has decreased by 7% from the previous quarter
MDT's debt is down by 6% since the previous quarter but it is up by 6% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.